REQUEST A DEMO
Total
USD $0.00
Search more companies

Merck Sharp & Dohme LLC (INTER AMERICAN) (Ecuador)

Main Activities: Pharmaceutical Preparation Manufacturing | Biological Product (except Diagnostic) Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Merck Sharp & Dohme LLC (INTER AMERICAN) Profile Updated: December 15, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Merck Sharp & Dohme LLC (INTER AMERICAN) is based in Ecuador, with the head office in Quito. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on March 20, 1973. Merck Sharp & Dohme LLC (INTER AMERICAN) currently employs 62 (2021) people. From the latest financial highlights, Merck Sharp & Dohme LLC (INTER AMERICAN) reported a net sales revenue increase of 10.55% in 2022. During that time, Merck Sharp & Dohme LLC (INTER AMERICAN)’s total assets grew by 37.74%. In, 2022, the company’s net profit margin increased by 3.65%.

Headquarters
Av. Naciones Unidas E10-44, Citiplaza Bldg. , Floor 6
Quito; Pichincha;

Contact Details: Purchase the Merck Sharp & Dohme LLC (INTER AMERICAN) report to view the information.

Basic Information
Total Employees:
Purchase the Merck Sharp & Dohme LLC (INTER AMERICAN) report to view the information.
Outstanding Shares:
Purchase the Merck Sharp & Dohme LLC (INTER AMERICAN) report to view the information.
Registered Capital:
Purchase the Merck Sharp & Dohme LLC (INTER AMERICAN) report to view the information.
Financial Auditors:
Purchase the Merck Sharp & Dohme LLC (INTER AMERICAN) report to view the information.
Incorporation Date:
March 20, 1973
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Merck Sharp & Dohme LLC (INTER AMERICAN) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
10.55%
Total operating revenue
18.48%
Operating profit (EBIT)
143.12%
EBITDA
125.42%
Net Profit (Loss) for the Period
155.76%
Total assets
37.74%
Total equity
15.62%
Operating Profit Margin (ROS)
5.3%
Net Profit Margin
3.65%
Return on Equity (ROE)
6.88%
Debt to Equity Ratio
-3.96%
Quick Ratio
-1.88%
Cash Ratio
-0.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?